Loading
iBio
iBio, Inc. is a biotech company. The Company develops next-generation biopharmaceuticals for cardiometabolic, obesity, cancer and other hard-to-treat diseases through AI and advanced computational biology. iBio operates in the United States.
Funding
Every round, secondary, debt facility or acquisition involving iBio that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—